Cargando…

High Mobility Group Box 1 in Human Cancer

High mobility group box 1 (HMGB1) is an extremely versatile protein that is located predominantly in the nucleus of quiescent eukaryotic cells, where it is critically involved in maintaining genomic structure and function. During cellular stress, however, this multifaceted, cytokine-like protein und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapoport, Bernardo L., Steel, Helen C., Theron, Annette J., Heyman, Liezl, Smit, Teresa, Ramdas, Yastira, Anderson, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407638/ https://www.ncbi.nlm.nih.gov/pubmed/32664328 http://dx.doi.org/10.3390/cells9071664

Ejemplares similares

Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy†
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
por: Rapoport, Bernardo L., et al.
Publicado: (2022)

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3
por: Rapoport, Bernardo L., et al.
Publicado: (2023)

Analysis of primary endocrine therapy in patients older than 70 years with breast cancer rejecting surgery from a single unit in South Africa including COVID-19 issues
por: Benn, Carol-Ann, et al.
Publicado: (2021)

Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer
por: Anderson, Ronald, et al.
Publicado: (2023)

Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
por: Theron, Annette J., et al.
Publicado: (2020)

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3(+), CD8(+), and Immunoscore Are Associated with a Pathological Complete Response
por: Rapoport, Bernardo Leon, et al.
Publicado: (2022)

Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells
por: Anderson, Ronald, et al.
Publicado: (2019)

A South African Breast Implant-Associated Anaplastic Large Cell Lymphoma: Clinical Presentation and Six-Year Follow-Up
por: Grubnik, Alexandra, et al.
Publicado: (2022)

A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
por: Leon Rapoport, Bernardo, et al.
Publicado: (2023)

Tuberculosis Infection in a Patient Treated With Nivolumab for Non-small Cell Lung Cancer: Case Report and Literature Review
por: van Eeden, Ronwyn, et al.
Publicado: (2019)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

Pharmacological control of neutrophil-mediated inflammation: Strategies targeting calcium handling by activated polymorphonuclear leukocytes
por: Tintinger, Gregory R, et al.
Publicado: (2009)

The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders
por: Theron, Annette J., et al.
Publicado: (2017)

ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
por: Anderson, Ronald, et al.
Publicado: (2020)

The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro
por: Anderson, Ronald, et al.
Publicado: (2014)

Clinical and prognostic significance of high-mobility group box-1 in human gliomas
por: WANG, XIN-JUN, et al.
Publicado: (2015)

Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C
por: Tintinger, Gregory R, et al.
Publicado: (2009)

Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
por: Steel, Helen C., et al.
Publicado: (2012)

First Intraoperative Radiation Therapy Center in Africa: First 2 Years in Operation, Including COVID-19 Experiences
por: Ramdas, Yastira, et al.
Publicado: (2020)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2012)

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
por: Theron, Annette J, et al.
Publicado: (2013)

Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
por: Tintinger, Gregory R., et al.
Publicado: (2015)

Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets
por: Madzime, Morris, et al.
Publicado: (2021)

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
por: Walker, Lauren Elizabeth, et al.
Publicado: (2017)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High mobility group box-1 and its clinical value in breast cancer
por: Sun, Shanping, et al.
Publicado: (2015)

The dual role and therapeutic potential of high-mobility group box 1 in cancer
por: He, Si-Jia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tup4haltrji5o3fev8ul6gpjh3